We present a comprehensive overview of approved cell and gene therapies. This comprehensive guide covers the essential aspects and latest developments within the field.
approved cell and gene therapies remains a foundational element in understanding the broader context. Our automated engine has curated the most relevant insights to provide you with a high-level overview.
"approved cell and gene therapies represents a significant milestone in our collective understanding of this niche."
Below you will find a curated collection of visual insights and related media gathered for approved cell and gene therapies.
Curated Insights
Apr 23, 2026 · Listing of licensed and approved products from the Office of Therapeutic Products (OTP).
Dec 11, 2025 · A complete, up-to-date list of every FDA-approved gene therapy and cell therapy — from Kymriah (2017) to the latest 2025 approvals. Includes pricing, indications, and approval dates.
Jan 21, 2025 · Professor's list of FDA-approved cell and gene therapies including stem cell therapies that have received FDA approval.
Nov 2, 2025 · Below is a list of all known cell and gene therapy products that have been licensed by the Office of Tissues and Advanced Therapies (OTAT), a division of the U.S. FDA.
There are seven CAR T-cell therapies and four other cell and gene therapies approved to treat various types of cancer. Here's the full list.
May 31, 2024 · Let’s ring in the new year with a list of all current FDA approved cell and gene therapies to date! Read on to learn more about the 34 different treatments and cures.
NEWDIGS maintains a list of approved durable cell and gene therapies (CGT), including approval dates for new biologics as well as supplemental indications. Durable cell and gene products are designed …
Over 40 FDA-approved cell and gene therapies are available by 2025. These treatments are varied, from CAR T-cell therapies to treatments for complex diseases like sickle cell disease.
In Europe, ExCellThera’s Zemcelpro, a non-genetically modified cell therapy for hematological malignancies, received authorization. While regulatory progress continued, clinical development …
Jan 23, 2025 · In 2024, new Cell and gene therapies (CGT) continued to make there way to the market, with the FDA approving nine innovative products in 2024 (FIG. 1). These therapies include stem cell …
Captured Moments
The bait you use.
